CashuOrganon & Company: New Leadership at May Health Amid Innovative PCOS Treatment Studyabout 1 year ago
CashuMay Health Appoints Ex-Organon Leader to Revolutionize PCOS Treatment with Ovarian Rebalancing™about 1 year ago
CashuOrganon & Company Supports May Health's Leadership Change in Pioneering PCOS Treatmentabout 1 year ago
simplywall.stA Look At Organon (OGN) Valuation After VTAMA Wins Key Pediatric Atopic Dermatitis Endorsementabout 10 hours ago
benzinga.comDow Dips Over 250 Points: Investor Sentiment Declines, Greed Index Remains In 'Fear' Zone8 days ago
thelincolnianonline.comXWELL (NASDAQ:XWEL) & Organon & Co. (NYSE:OGN) Head to Head Comparison13 days ago